Cargando…
The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
Trace amine-associated receptors (TAARs) belong to the class A G-protein-coupled receptors (GPCR) and are evolutionary related to aminergic receptors. TAARs have been identified to mediate effects of trace amines. TAAR1 signaling is mainly mediated via activation of the G(s)/adenylyl cyclase pathway...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857711/ https://www.ncbi.nlm.nih.gov/pubmed/29593543 http://dx.doi.org/10.3389/fphar.2018.00222 |
_version_ | 1783307520687734784 |
---|---|
author | Bräunig, Julia Dinter, Juliane Höfig, Carolin S. Paisdzior, Sarah Szczepek, Michal Scheerer, Patrick Rosowski, Mark Mittag, Jens Kleinau, Gunnar Biebermann, Heike |
author_facet | Bräunig, Julia Dinter, Juliane Höfig, Carolin S. Paisdzior, Sarah Szczepek, Michal Scheerer, Patrick Rosowski, Mark Mittag, Jens Kleinau, Gunnar Biebermann, Heike |
author_sort | Bräunig, Julia |
collection | PubMed |
description | Trace amine-associated receptors (TAARs) belong to the class A G-protein-coupled receptors (GPCR) and are evolutionary related to aminergic receptors. TAARs have been identified to mediate effects of trace amines. TAAR1 signaling is mainly mediated via activation of the G(s)/adenylyl cyclase pathway. In addition to classical trace amines, TAAR1 can also be activated by the thyroid hormone derivative 3-iodothyronamine (3-T1AM). Pharmacological doses of 3-T1AM induced metabolic and anapyrexic effects, which might be centrally mediated in the hypothalamus in rodents. However, the observed anapyrexic effect of 3-T1AM persists in Taar1 knock-out mice which raises the question whether further GPCRs are potential targets for 3-T1AM and mediate the observed physiological effect. Anapyrexia has been observed to be related to action on aminergic receptors such as the serotonin receptor 1b (5-HT1b). This receptor primarily activates the G(i/o) mediated pathway and PLC signaling through the G(β)γ of G(i/o). Since the expression profiles of TAAR1 and 5-HT1b overlap, we questioned whether 3-T1AM may activate 5-HT1b. Finally, we also evaluated heteromerization between these two GPCRs and tested signaling under co-expressed conditions. In this study, we showed, that 3-T1AM can induce G(i/o) signaling through 5-HT1b in a concentration of 10 μM. Strikingly, at 5-HT1b the ligand 3-T1AM only activates the G(i/o) mediated reduction of cAMP accumulation, but not PLC activation. Co-stimulation of 5-HT1b by both ligands did not lead to additive or synergistic signaling effects. In addition, we confirmed the capacity for heteromerization between TAAR1 and 5-HT1b. Under co-expression of TAAR1 and HTR1b, 3-T1AM action is only mediated via TAAR1 and activation of 5-HT1b is abrogated. In conclusion, we found evidence for 5-HT1b as a new receptor target for 3-T1AM, albeit with a different signaling effect than the endogenous ligand. Altogether, this indicates a complex interrelation of signaling effects between the investigated GPCRs and respective ligands. |
format | Online Article Text |
id | pubmed-5857711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58577112018-03-28 The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor Bräunig, Julia Dinter, Juliane Höfig, Carolin S. Paisdzior, Sarah Szczepek, Michal Scheerer, Patrick Rosowski, Mark Mittag, Jens Kleinau, Gunnar Biebermann, Heike Front Pharmacol Pharmacology Trace amine-associated receptors (TAARs) belong to the class A G-protein-coupled receptors (GPCR) and are evolutionary related to aminergic receptors. TAARs have been identified to mediate effects of trace amines. TAAR1 signaling is mainly mediated via activation of the G(s)/adenylyl cyclase pathway. In addition to classical trace amines, TAAR1 can also be activated by the thyroid hormone derivative 3-iodothyronamine (3-T1AM). Pharmacological doses of 3-T1AM induced metabolic and anapyrexic effects, which might be centrally mediated in the hypothalamus in rodents. However, the observed anapyrexic effect of 3-T1AM persists in Taar1 knock-out mice which raises the question whether further GPCRs are potential targets for 3-T1AM and mediate the observed physiological effect. Anapyrexia has been observed to be related to action on aminergic receptors such as the serotonin receptor 1b (5-HT1b). This receptor primarily activates the G(i/o) mediated pathway and PLC signaling through the G(β)γ of G(i/o). Since the expression profiles of TAAR1 and 5-HT1b overlap, we questioned whether 3-T1AM may activate 5-HT1b. Finally, we also evaluated heteromerization between these two GPCRs and tested signaling under co-expressed conditions. In this study, we showed, that 3-T1AM can induce G(i/o) signaling through 5-HT1b in a concentration of 10 μM. Strikingly, at 5-HT1b the ligand 3-T1AM only activates the G(i/o) mediated reduction of cAMP accumulation, but not PLC activation. Co-stimulation of 5-HT1b by both ligands did not lead to additive or synergistic signaling effects. In addition, we confirmed the capacity for heteromerization between TAAR1 and 5-HT1b. Under co-expression of TAAR1 and HTR1b, 3-T1AM action is only mediated via TAAR1 and activation of 5-HT1b is abrogated. In conclusion, we found evidence for 5-HT1b as a new receptor target for 3-T1AM, albeit with a different signaling effect than the endogenous ligand. Altogether, this indicates a complex interrelation of signaling effects between the investigated GPCRs and respective ligands. Frontiers Media S.A. 2018-03-12 /pmc/articles/PMC5857711/ /pubmed/29593543 http://dx.doi.org/10.3389/fphar.2018.00222 Text en Copyright © 2018 Bräunig, Dinter, Höfig, Paisdzior, Szczepek, Scheerer, Rosowski, Mittag, Kleinau and Biebermann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Bräunig, Julia Dinter, Juliane Höfig, Carolin S. Paisdzior, Sarah Szczepek, Michal Scheerer, Patrick Rosowski, Mark Mittag, Jens Kleinau, Gunnar Biebermann, Heike The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title | The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title_full | The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title_fullStr | The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title_full_unstemmed | The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title_short | The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor |
title_sort | trace amine-associated receptor 1 agonist 3-iodothyronamine induces biased signaling at the serotonin 1b receptor |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857711/ https://www.ncbi.nlm.nih.gov/pubmed/29593543 http://dx.doi.org/10.3389/fphar.2018.00222 |
work_keys_str_mv | AT braunigjulia thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT dinterjuliane thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT hofigcarolins thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT paisdziorsarah thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT szczepekmichal thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT scheererpatrick thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT rosowskimark thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT mittagjens thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT kleinaugunnar thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT biebermannheike thetraceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT braunigjulia traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT dinterjuliane traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT hofigcarolins traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT paisdziorsarah traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT szczepekmichal traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT scheererpatrick traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT rosowskimark traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT mittagjens traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT kleinaugunnar traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor AT biebermannheike traceamineassociatedreceptor1agonist3iodothyronamineinducesbiasedsignalingattheserotonin1breceptor |